Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

http://www.wikidata.org/entity/Q37577111

about

Evaluation Series on Safety and Efficacy of Nutritional Supplements in Newly Diagnosed Hyperglycemia: A Placebo-Controlled, Randomized Study.Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran Microvascular Complications and Their Associated Risk Factors in Newly Diagnosed Type 2 Diabetes Mellitus Patients.Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes.Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes.Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date Effect of metformin on the incidence of head and neck cancer in diabetics.Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach.

P2860

Q30386420-EC98758F-DF6E-4C6D-929C-14D2619FE28F Q33612248-61890FA6-8B15-4614-AD5C-E89390155C6B Q33652884-16A72D55-47BD-46DD-91EE-90A7C8F8FFCD Q33834266-9CDFAEAC-F007-4E51-9788-16C98D1E8536 Q35763250-2D9BDA3C-589E-49ED-BE58-3B86FAF283DA Q36112535-D31C71BB-E3B1-48DD-A661-A2802EBCBE0B Q38387034-4A7EA123-E269-4A17-8C80-ADAA95B9E0F5 Q38599975-5D415E70-B537-4B25-8BC2-A4C21AFAF72E Q38672852-277A3A31-361C-4424-BB3B-A0B6F09AC7F5 Q39005558-A720D7BF-854D-45FF-AF9E-EFB6759BA594 Q41702839-0904EA2F-2485-4B82-AAEB-C21133995ED7 Q42373168-D105EA80-1AB0-43A3-A0B5-CF2E5D410228 Q46006826-903BD2C4-BF00-4075-B1FE-89FF12C1580E Q48140061-4ABEED29-1FF4-41B4-99A2-099301D218BD

P2860

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

http://www.wikidata.org/entity/Q37577111

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@en

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@nl

type

label

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@en

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@nl

prefLabel

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@en

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@nl

P1433

Q37577111-409D0BFC-7B1E-47C4-8804-45CCD69E6415

P1476

Q37577111-4846D98F-C353-43E0-8DC6-80AE530426EB

P2093

Q37577111-ED1F9C4F-F8C1-4686-BDDE-24A6FC11A762

P2860

Q37577111-009D9F0B-8C4D-4547-9683-61BADD6379FC

Q37577111-0362DE9B-EF19-4455-AA42-5B28CCE6F3F0

Q37577111-048EFA9A-496F-4B52-B875-4663CFE846E7

Q37577111-04BCE76B-1131-4B2C-B762-B3EDB233B335

Q37577111-0EE6E251-E0A9-4C75-8590-D538AEC0C561

Q37577111-137C87B9-5BC1-4069-98E2-487BA9648C19

Q37577111-1402A9C7-3A7F-4568-8407-A292478FCD38

Q37577111-1701CF8D-9338-40E3-9C64-E2B3F0F6EA28

Q37577111-1A6FBE43-2181-453D-9BD5-0D61DF1CED31

Q37577111-3B4CF1EA-EC19-4322-BD56-7AEE51147BD2

P304

Q37577111-067DA88E-8110-4A81-959B-9B49849AD8C1

P31

Q37577111-F7B229F4-56EB-4DB2-B152-06140317FCA6

P356

Q37577111-F397321D-1FEE-43CB-824A-5ABD89422CB8

P407

Q37577111-0333809B-DEC2-48D2-AB8A-16CB668DAD53

P478

Q37577111-D0087881-0C4B-40CB-B2AA-7E8E5D92AE1D

P577

Q37577111-D2EC89E3-86CF-4116-B60C-67782B69FD73

P5875

Q37577111-7EA85899-B92E-4757-B87C-678DDC20CBBB

P698

Q37577111-942DC0AD-BE5E-45A9-AFC3-30AE68049902

P921

Q37577111-30EE9B3C-8892-44D0-8516-C227577839C2

P932

Q37577111-6860BA1E-2262-4217-9D20-4A5000D642AA

P356

P1433

P1476

Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.

@en

P2093

Itamar Raz

http://www.w3.org/2001/XMLSchema#string

P2860

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Can diabetes prevention programmes be translated effectively into real-world settings and still deliver improved outcomes? A synthesis of evidence

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

10-year follow-up of intensive glucose control in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

P304

S139-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DCS13-2035

http://www.w3.org/2001/XMLSchema#string

P407

P478

36 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271055356

http://www.w3.org/2001/XMLSchema#string

P698

23882038

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3920774

http://www.w3.org/2001/XMLSchema#string